Cargando…
Decreased risk of Parkinson’s disease in diabetic patients with thiazolidinediones therapy: An exploratory meta-analysis
BACKGROUND: It has been found that thiazolidinediones (TZDs) may play a protective role in animal models of Parkinson’s disease (PD), while the results remain controversial whether TZDs protect against Parkinson’s disease in humans. The purpose of this meta-analysis is to explore the association bet...
Autores principales: | Zhu, Yueli, Pu, Jiali, Chen, Yanxing, Zhang, Baorong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804998/ https://www.ncbi.nlm.nih.gov/pubmed/31639149 http://dx.doi.org/10.1371/journal.pone.0224236 |
Ejemplares similares
-
Thiazolidinedione use and risk of Parkinson’s disease in patients with type 2 diabetes mellitus
por: Zhao, Houyu, et al.
Publicado: (2022) -
Thiazolidinediones and risk of colorectal cancer in patients with diabetes mellitus: A meta-analysis
por: Liu, Yang, et al.
Publicado: (2018) -
Structure, Distribution, and Genetic Profile of α-Synuclein and Their Potential Clinical Application in Parkinson’s Disease
por: Si, Xiaoli, et al.
Publicado: (2017) -
Risk of Fracture with Thiazolidinediones: Disease or Drugs?
por: Bazelier, Marloes T., et al.
Publicado: (2012) -
Thiazolidinediones: the Forgotten Diabetes Medications
por: Lebovitz, Harold E.
Publicado: (2019)